Randomized trial of r-metHu granulocyte colony-stimulating factor in an intensive treatment for T-cell leukemia and advanced-stage lymphoblastic lymphoma of childhood: A pediatric oncology group pilot study

Journal of Clinical Oncology

Volumn 16, Issue 2, 1998, Pages 522-526

  Laver, Joseph ^a   Amylon, Michael ^a   Desai, Sunil ^a   Link, Michael ^a   Schwenn, Molly ^a   Mahmoud, Hazem ^a   Shuster, Jonathan ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; MERCAPTOPURINE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADVANCED CANCER; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL TRIAL; COHORT ANALYSIS; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; T CELL LEUKEMIA;

EID: 0031953539     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.2.522     Document Type: Article

References (16)

1. Gupta S, Good RA: Markers of human lymphocyte subpopulations in primary immunodeficiency and lymphoproliferative disorders. Semin Hematol 17:1-29, 1980
2. Roper M, Crist WM, Metzgar R, et al: Monoclonal antibody characterization of surface antigens in childhood T-cell lymphoid malignancies. Blood 61:830-837, 1983
3. Tsukimoto I, Wang KY, Lampkin BC: Surface markers and prognostic factors in acute lymphoblastic leukemia. N Engl J Med 294:245-248, 1976
4. 2 treatment in 53 children with E-rosette positive T-ceil leukemia: Results and prognostic factors (A Pediatric Oncology Group study) Blood 60:1159-1168, 1982
5. 2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded). Cancer 55:323-326, 1985
6. Amylon MD, Shuster J, Pullen J, et al: Intensive high dose asparaginase consolidation improves survival for pediatric patients with T-cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: Pediatric Oncology Group study 8704. (submitted for publication)
7. Gabrilove JL, Jakubowski A, Scher H, et al: Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 318:1414-1422, 1988
8. Morstyn G, Campbell L, Souza LM, et al: Effect of granulocyte colony-stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1:667-672, 1988
9. Murphy SB: Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: Dissimilarities from lymphomas in adults. Semin Oncol 7:332-339, 1980
10. Laver J, Moore MAS: Clinical use of hematopoietic growth factors. J Natl Cancer Inst 81:1370-1382, 1989
11. Ottmann OG, Hoelzer D, Gracien E, et al: Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: A randomized phase III trial. Blood 86:444-450, 1995
12. Weite K, Reiter A, Mempel K, et al: A randomized phase III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Blood 87:3143-3150, 1996
13. Wexler LH, Weaver-McClure L, Steinberg SM, et al: Randomized trial of recombinant human granulocyte-macrophage colony-stimulating factor in pediatric patients receiving intensive myelosuppressive chemotherapy. J Clin Oncol 14:901-910, 1996
14. Brochund MH, Howell A, Crowther D, et al: The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast cancer. Br J Cancer 60:121-127, 1989
15. Gerhartz HH, Engehard M, Meusers P, et al: Randomized, double blind, placebo-controlled phase III study of recombinant human granulocyte colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomas. Blood 82:2278-280, 1993
16. Weite K, Gabrilove J, Brochund MH, et al: Filgrastim (r-metHuG-CSF): The first 10 years. Blood 88:1907-1929, 1996